Decline in Cardiovascular Mortality: Framingham 1950-1984

NCT00005222 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2016-05-13

No results posted yet for this study

Summary

To investigate possible mechanisms responsible for the decline in cardiovascular disease mortality among the Framingham Heart Study population and to evaluate the health status of survivors in terms of subsequent illness and functional limitations.

Conditions

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    lead NIH

Eligibility

Max Age
100 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1988-04-30
Completion
1996-03-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00005222 on ClinicalTrials.gov